2Q PREVIEW: Pfizer, Merck, Amgen try to recapture momentum
This article was originally published in Scrip
Executive Summary
Once the envy of the industry, Pfizer and Merck & Co. are both expected to report lower quarterly profit this week as generic rivals chomp away at sales.